First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...